Efficacy of low dose intravenous immunoglobulins for post-splenectomy treatment of autoimmune haemolytic anaemia in a patient with hereditary spherocytosis

P R Ames; S Nardiello; C Tommasino

doi:10.1046/j.1365-2257.2000.00310.x

Efficacy of low dose intravenous immunoglobulins for post-splenectomy treatment of autoimmune haemolytic anaemia in a patient with hereditary spherocytosis

Clin Lab Haematol. 2000 Aug;22(4):225-8. doi: 10.1046/j.1365-2257.2000.00310.x.

Authors

P R Ames¹, S Nardiello, C Tommasino

Affiliation

¹ Department of Haematology, Guy's & St Thomas' Hospital Trust, London, UK. pames@rayne.umds.ac.uk

PMID: 11012635
DOI: 10.1046/j.1365-2257.2000.00310.x

Abstract

Summary Idiopathic autoimmune haemolytic anaemia developed in a patient with hereditary spherocytosis. The behaviour of some osmotic fragility tests throughout the illness and the efficacy of intravenous immunoglobulins in controlling autoimmune haemolysis which recurred post splenectomy are discussed

Publication types

Case Reports

MeSH terms

Adult
Anemia, Hemolytic, Autoimmune / drug therapy*
Anemia, Hemolytic, Autoimmune / etiology
Family Health
Humans
Immunoglobulins, Intravenous / standards*
Immunoglobulins, Intravenous / therapeutic use
Male
Spherocytosis, Hereditary / complications
Spherocytosis, Hereditary / drug therapy
Splenectomy*
Time Factors

Substances

Immunoglobulins, Intravenous